Titan Pharmaceuticals
TTNP
#10415
Rank
S$7.87 M
Marketcap
S$5.92
Share price
-3.76%
Change (1 day)
34.89%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -S$3.69 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$6.05 Million, an increase over its 2023 earnings that were of -S$7.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$3.69 Million-39.04%
2024 -S$6.05 Million-15.5%
2023 -S$7.16 Million-45.43%
2022 -S$13.12 Million16.29%
2021 -S$11.28 Million-907.36%
2020 S$1.39 M-106.6%
2019 -S$21.15 Million82.4%
2018 -S$11.6 Million-36.93%
2017 -S$18.39 Million-378.62%
2016 S$6.59 M-145.53%
2015 -S$14.5 Million369.37%
2014 -S$3.09 Million-125.9%
2013 S$11.92 M-177.74%
2012 -S$15.34 Million13.59%
2011 -S$13.5 Million74.37%
2010 -S$7.75 Million3.61%
2009 -S$7.48 Million
2007 -S$23.69 Million12.08%
2006 -S$21.14 Million-28.65%
2005 -S$29.62 Million-10.03%
2004 -S$32.93 Million-6.08%
2003 -S$35.06 Million-14.76%
2002 -S$41.13 Million32.52%
2001 -S$31.04 Million27.55%
2000 -S$24.33 Million62.5%
1999 -S$14.98 Million4.04%
1998 -S$14.4 Million49.33%
1997 -S$9.64 Million-27.88%
1996 -S$13.37 Million13.04%
1995 -S$11.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-S$15.43 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.33 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.62 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.09 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
S$33.59 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA